Literature DB >> 12241721

Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease.

Antonio Luiz P Ribeiro1, Adelina Martha dos Reis, Marcio Vinicius L Barros, Marcos Roberto de Sousa, Ana Luiza L Rocha, Amanda Arantes Perez, Jacqueline Braga Pereira, Fernando Santana Machado, Manoel Otávio C Rocha.   

Abstract

Left ventricular dysfunction in Chagas' disease is common but can be difficult to detect. We investigated whether measurement of plasma brain natriuretic peptide (BNP) could identify patients with left ventricular dysfunction who need further investigation or treatment. Among patients with an abnormal electrocardiogram or chest radiograph, a BNP concentration of 60.7 pmol/L or higher has a sensitivity and positive predictive value of 80%, and specificity and negative predictive value of 97%. Measurement of plasma BNP concentration could be a useful method to screen patients with Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12241721     DOI: 10.1016/S0140-6736(02)09638-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

1.  Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.

Authors:  S M Keating; X Deng; F Fernandes; E Cunha-Neto; A L Ribeiro; B Adesina; A I Beyer; P Contestable; B Custer; M P Busch; E C Sabino
Journal:  Int J Cardiol       Date:  2015-07-12       Impact factor: 4.164

2.  Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.

Authors:  Juan C Engel; Kenny K H Ang; Steven Chen; Michelle R Arkin; James H McKerrow; Patricia S Doyle
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

Review 3.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 4.  Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.

Authors:  V Balouz; F Agüero; C A Buscaglia
Journal:  Adv Parasitol       Date:  2016-11-14       Impact factor: 3.870

Review 5.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

6.  Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients.

Authors:  Ana Luiza Lunardi Rocha; Federico Lombardi; Manoel Otávio da Costa Rocha; Márcio Vinícius Lins Barros; Vladimir da Costa Val Barros; Adelina Martha Reis; Antonio Luiz Pinho Ribeiro
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

7.  Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage.

Authors:  Ana Garcia-Alvarez; Marta Sitges; María-Jesús Pinazo; Ander Regueiro-Cueva; Elizabeth Posada; Silvia Poyatos; José Tomás Ortiz-Pérez; Magda Heras; Manel Azqueta; Joaquim Gascon; Ginés Sanz
Journal:  PLoS Negl Trop Dis       Date:  2010-09-21

Review 8.  Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies.

Authors: 
Journal:  Arq Bras Cardiol       Date:  2014-11-28       Impact factor: 2.000

9.  Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging.

Authors:  Antonio Luiz P Ribeiro; Milena S Marcolino; Ronald J Prineas; Maria Fernanda Lima-Costa
Journal:  J Am Heart Assoc       Date:  2014-02-07       Impact factor: 5.501

10.  Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile.

Authors:  Clareci Silva Cardoso; Ester Cerdeira Sabino; Claudia Di Lorenzo Oliveira; Lea Campos de Oliveira; Ariela Mota Ferreira; Edécio Cunha-Neto; Ana Luiza Bierrenbach; João Eduardo Ferreira; Desirée Sant'Ana Haikal; Arthur L Reingold; Antonio Luiz P Ribeiro
Journal:  BMJ Open       Date:  2016-05-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.